| Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials A Messori, S Trippoli, M Vaiani, M Gorini, A Corrado Bmj 321 (7269), 1103, 2000 | 339 | 2000 |
| Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia S Trippoli, M Vaiani, S Linari, G Longo, M Morfini, A Messori Haematologica 86 (7), 722-728, 2001 | 160 | 2001 |
| Quality of life and utility in patients with non-small cell lung cancer S Trippoli, M Vaiani, C Lucioni, A Messori, ... Pharmacoeconomics 19, 855-863, 2001 | 150 | 2001 |
| Survival in patients with intermediate or high grade non-Hodgkin’s lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP A Messori, M Vaiani, S Trippoli, L Rigacci, M Jerkeman, G Longo British journal of cancer 84 (3), 303-307, 2001 | 117 | 2001 |
| Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoeconomico A Messori, B Santarlasci, S Trippoli, M Vaiani PharmacoEconomics Italian Research Articles 2 (5), 53-67, 2003 | 75 | 2003 |
| Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost–utility analysis A Messori, S Trippoli, P Becagli, M Cincotta, MG Labbate, G Zaccara European journal of clinical pharmacology 53, 421-427, 1998 | 66 | 1998 |
| Pharmacoeconomic profile of paclitaxel as a first‐line treatment for patients with advanced ovarian carcinoma: A lifetime cost‐effectiveness analysis A Messori, S Trippoli, P Becagli, E Tendi Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 52 | 1996 |
| Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+ methotrexate+ fluorouracil in patients with node-positive breast cancer A Messori, P Becagli, S Trippoli, E Tendi European journal of clinical pharmacology 51, 111-116, 1996 | 48 | 1996 |
| G‐CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta‐analysis and … A Messori, S Trippoli, E Tendi Journal of Clinical Pharmacy and therapeutics 21 (2), 57-63, 1996 | 48 | 1996 |
| A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma A Messori, P Becagli, S Trippoli, E Tendi European Journal of Cancer 33 (9), 1373-1379, 1997 | 44 | 1997 |
| Results can be summarised in a simple figure V Fadda, D Maratea, S Trippoli, A Messori BMJ: British Medical Journal (Online) 342, 2011 | 41 | 2011 |
| ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from “no proof of effectiveness” to “proof of no effectiveness” A Messori, V Fadda, D Maratea, S Trippoli JAMA internal medicine 173 (15), 1466-1468, 2013 | 40 | 2013 |
| Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis F Del Santo, D Maratea, V Fadda, S Trippoli, A Messori European journal of clinical pharmacology 68, 441-448, 2012 | 40 | 2012 |
| Cost effectiveness of riluzole in amyotrophic lateral sclerosis A Messori, S Trippoli, P Becagli, G Zaccara Pharmacoeconomics 16, 153-163, 1999 | 37 | 1999 |
| The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit A Messori, S Trippoli Heart 103 (21), 1746-1746, 2017 | 31 | 2017 |
| Stent-retriever thrombectomy for stroke OA Berkhemer, WH van Zwam, DW Dippel, MR CLEAN Investigators N Engl J Med 373 (11), 1076, 2015 | 31 | 2015 |
| Incremental cost-effectiveness ratio and net monetary benefit: current use in pharmacoeconomics and future perspectives S Trippoli European Journal of Internal Medicine 43, e36, 2017 | 30 | 2017 |
| Antithrombin III in patients admitted to intensive care units: a multicenter observational study A Messori, F Vacca, M Vaiani, S Trippoli, ... Critical Care 6, 1-5, 2002 | 30 | 2002 |
| Biological meshes for abdominal hernia: Lack of evidence-based recommendations for clinical use S Trippoli, E Caccese, G Tulli, P Ipponi, C Marinai, A Messori International Journal of Surgery 52, 278-284, 2018 | 27 | 2018 |
| Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis A Messori, V Fadda, D Maratea, S Trippoli, C Marinai Clinical infectious diseases 57 (12), 1783-1784, 2013 | 27 | 2013 |
